Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.

Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M.

Biol Psychiatry. 2004 Feb 15;55(4):406-12.

PMID:
14960294
2.
3.

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.

Rudolph I, Palombo-Kinne E, Kirsch B, Mellinger U, Breitbarth H, Gräser T.

Climacteric. 2004 Sep;7(3):301-11.

PMID:
15669555
4.
5.

Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.

Curran MP, Wagstaff AJ.

Treat Endocrinol. 2002;1(2):127-9. Review.

PMID:
15765628
6.

Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.

Dias RS, Kerr-Corrêa F, Moreno RA, Trinca LA, Pontes A, Halbe HW, Gianfaldoni A, Dalben IS.

Menopause. 2006 Mar-Apr;13(2):202-11.

PMID:
16645534
7.

Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.

Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.

Psychosom Med. 2005 Jan-Feb;67(1):98-104.

PMID:
15673630
8.

Estrogen replacement in perimenopause-related depression: a preliminary report.

Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR.

Am J Obstet Gynecol. 2000 Aug;183(2):414-20.

PMID:
10942479
9.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
10.

Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.

Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B.

Climacteric. 2002 Dec;5(4):357-65.

PMID:
12626215
11.
12.

Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.

Baksu B, Baksu A, Göker N, Citak S.

Maturitas. 2009 Feb 20;62(2):140-5. doi: 10.1016/j.maturitas.2008.12.010.

PMID:
19179026
13.
15.

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.

Rowan JP, Simon JA, Speroff L, Ellman H.

Clin Ther. 2006 Jun;28(6):921-32. Erratum in: Clin Ther. 2006 Aug;28(8):1244.

PMID:
16860174
16.

A comparison of the central effects of different progestins used in hormone replacement therapy.

Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A.

Maturitas. 2004 Aug 20;48(4):456-62.

PMID:
15283939
17.
18.

Estrogen therapy for depression in postmenopausal women.

Carranza-Lira S, Valentino-Figueroa ML.

Int J Gynaecol Obstet. 1999 Apr;65(1):35-8.

PMID:
10390097
19.

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.

Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.

Menopause. 2006 Jan-Feb;13(1):130-8.

PMID:
16607109
20.

Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.

Fernandes EO, Moraes RS, Ferlin EL, Wender MC, Ribeiro JP.

Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S172-7.

PMID:
15683490
Items per page

Supplemental Content

Support Center